Impulse (Qingdao) Health Tech Co.,Ltd.

SZSE:002899.SZ

14.94 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 320.73330.628238.399236.759263.406196.259198.895257.505190.133182.822194.237236.642182.797220.385224.571298.304218.049210.808140.823311.378237.714209.201179.32312.707224.464196.411174.081292.638202.24206.157156.196248.706198.369165.79165.79
Cost of Revenue 213.904229.658171.327159.465181.245116.506152.922175.519146.695132.593153.734209.087126.84146.989160.334195.604150.919137.80598.529191.797155.918143.523127.616210.634148.103133.372125.798182.972132.233124.28396.693134.954126.24800
Gross Profit 106.827100.9767.07277.29482.16179.75345.97381.98643.43850.22940.50227.55555.95873.39664.237102.70167.1373.00442.293119.58181.79665.67951.704102.07376.36163.03948.283109.66770.00881.87459.504113.75272.121165.79165.79
Gross Profit Ratio 0.3330.3050.2810.3260.3120.4060.2310.3180.2280.2750.2090.1160.3060.3330.2860.3440.3080.3460.30.3840.3440.3140.2880.3260.340.3210.2770.3750.3460.3970.3810.4570.36411
Reseach & Development Expenses 13.8738.80913.2812.4410.8047.01510.82911.1418.1019.38311.26711.6237.76416.12311.09625.77211.05521.6910.81232.00216.89213.80410.6959.92111.03723.4127.13338.88018.694039.92000
General & Administrative Expenses 0-2.81316.084-18.45332.152-3.37612.434-19.74429.528-4.58112.255-22.97432.298-3.42513.429-21.63213.553-4.41710.382-20.5412.542-5.99212.93-46.68322.55-9.76217.442-46.13921.40820.2320.178-52.41821.70700
Selling & Marketing Expenses 012.65622.10522.78214.47513.01617.42812.67816.96910.18818.212-17.41127.31317.63232.65635.17226.25721.76119.92957.11225.93528.3422.92853.16121.33229.96123.13848.36222.2225.29817.88257.20813.06500
SG&A 45.60445.23338.1894.32946.6279.64129.862-7.06646.4975.60730.467-40.38559.6114.20646.08513.5439.8117.34430.31136.57338.47822.34835.8586.47843.88220.240.582.22343.62845.52838.064.7934.77200
Other Expenses -2.925-1.508-0.209-0.543-0.02-0.022-0.838.327-17.40915.640.412-20.488-2.2740.321-0.023-0.9590.08-0.069-0.0081.505-0.0760.022-0.002-1.3260.6460.3985.1920.3870.7070.7090.2091.0160.3200
Operating Expenses 62.40255.5552.1162.48640.63134.66339.89242.40237.18930.6342.1457.37849.94250.23156.24677.30848.16655.28142.662109.76454.9154.22648.37782.06147.13153.53642.45778.53847.29247.75340.44485.69935.96148.554148.554
Operating Income 44.42445.42115.89819.18141.23437.0374.50616.2816.01829.914-1.6437.9688.66413.989.3439.34813.42915.0973.7962.33734.48214.1433.23117.64731.91614.8622.18623.35820.67330.31418.60930.26936.34416.62716.627
Operating Income Ratio 0.1390.1370.0670.0810.1570.1890.0230.0630.0840.164-0.0080.0340.0470.0630.0420.0310.0620.0720.0270.0080.1450.0680.0180.0560.1420.0760.0130.080.1020.1470.1190.1220.1830.10.1
Total Other Income Expenses Net -4.868-2.1590.727-5.91-0.02-0.022-0.169-2.908-0.008-16.0013.775-20.4880.374-8.8641.329-17.004-5.455-2.6954.156-5.9757.522.712-0.098-3.6913.3335.7571.553-7.384-1.336-312.271-0.2432.2110.5030.6090.609
Income Before Tax 39.55643.26215.68918.63841.21437.0154.33713.37216.0113.9122.132-12.5196.38914.39.328.38913.50915.0283.7883.84234.40614.1653.22916.32132.56315.267.37923.74421.3831.02218.81730.26436.66417.23517.235
Income Before Tax Ratio 0.1230.1310.0660.0790.1560.1890.0220.0520.0840.0760.011-0.0530.0350.0650.0420.0280.0620.0710.0270.0120.1450.0680.0180.0520.1450.0780.0420.0810.1060.150.120.1220.1850.1040.104
Income Tax Expense 3.3765.9761.8043.1285.6433.2880.982-22.7021.906-0.240.797-1.827-2.0781.7942.17-4.0761.6632.4981.066-5.347.6311.8920.902-0.5784.9443.081.3891.1921.8095.443.3535.2095.6512.6752.675
Net Income 36.14937.2813.88515.5135.57133.7273.35536.07414.10414.1521.335-10.6928.46712.5077.1512.46411.84612.532.7229.18226.77612.2732.32716.89927.61812.185.9922.55219.57225.58215.46425.05531.01314.56114.561
Net Income Ratio 0.1130.1130.0580.0660.1350.1720.0170.140.0740.0770.007-0.0450.0460.0570.0320.0420.0540.0590.0190.0290.1130.0590.0130.0540.1230.0620.0340.0770.0970.1240.0990.1010.1560.0880.088
EPS 0.250.280.120.120.30.280.0280.30.110.110.01-0.110.0710.10.060.110.10.0920.020.0750.220.110.020.140.230.10.050.250.220.280.170.270.340.1610.162
EPS Diluted 0.250.280.120.120.30.280.0280.30.110.110.01-0.110.0710.10.060.110.10.0920.020.0750.220.110.020.140.230.10.050.250.220.280.170.270.340.1610.162
EBITDA 45.68155.50619.267.5554.21354.7396.80733.80516.00629.904-1.923-1.5896.16321.94110.1519.93712.34119.1052.50612.27736.84715.44.57220.96636.05518.2695.03225.9522.975343.29322.07233.35535.70417.80717.807
EBITDA Ratio 0.1420.1680.0810.0320.2060.2790.0340.1310.0840.164-0.01-0.0070.0340.10.0450.0670.0570.0910.0180.0390.1550.0740.0250.0670.1610.0930.0290.0890.1141.6650.1410.1340.180.1070.107